SEC Form 4 · accession 0001209191-15-020049
REPLIGEN CORP · RGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James R Rusche
Officer — Senior Vice President
Period of report
Feb 26, 2015
Accepted (ET)
Mar 2, 2015 · 8:29 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000730272
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 26, 2015 | A | 5,229 | $0.00 | A | 126,499 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $24.98 | Feb 26, 2015 | A | 10,067 | A | — | Feb 26, 2025 | Common Stock | 10,067 | 10,067 | D |
Explanation of responses
- F1Mr. Rusche was awarded 5,229 Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The Restricted Stock Units vest in equal annual installments over a three-year period beginning on the first anniversary of the grant date. The Restricted Stock Units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
- F2The shares vest in equal annual installments over a three-year period beginning on the first anniversary of the grant date.